
Everist Genomics provides personalized medicine solutions that help researchers identify clinically relevant biological patterns from complex datasets. The company applies a proprietary machine-learning platform (Evolver) that generates mathematical models tailored to specific research questions to support clinical and preclinical studies. Its technology is used in oncology, infectious disease, nephrology, and autoimmune research to derive actionable insights from genomic and biomedical data. Everist Genomics operates as a biotechnology/life‑sciences solutions provider selling to research institutions and clinical teams, and is based in Ann Arbor, Michigan.

Everist Genomics provides personalized medicine solutions that help researchers identify clinically relevant biological patterns from complex datasets. The company applies a proprietary machine-learning platform (Evolver) that generates mathematical models tailored to specific research questions to support clinical and preclinical studies. Its technology is used in oncology, infectious disease, nephrology, and autoimmune research to derive actionable insights from genomic and biomedical data. Everist Genomics operates as a biotechnology/life‑sciences solutions provider selling to research institutions and clinical teams, and is based in Ann Arbor, Michigan.
Headquarters: Ann Arbor, Michigan
Sector: Biotechnology / Personalized medicine / Diagnostics
Core offering: Proprietary ML platform (Evolver) for deriving actionable insights from genomic and biomedical data
Founded: 2001
Known investor: CrystalPoint Partners
Translating complex genomic and biomedical datasets into clinically relevant, actionable insights for research and clinical decision support.
2001
Biotechnology
1821000
“CrystalPoint Partners”